XML 26 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounting Policies - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 29, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2012
Jun. 30, 2012
Dec. 31, 2011
Jun. 30, 2011
Sep. 30, 2010
Dec. 31, 2013
Y
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Summary Of Significant Accounting Policies [Line Items]                                  
Depreciation over life to cost of revenues and selling and administrative expenses, years                           6      
Net book value of internally manufactured test systems sold                           $ 9,000,000 $ 6,000,000 $ 7,800,000  
Percentage of common stock price                           85.00% 85.00% 85.00%  
Stock options term                           7 years      
Restricted stock unit awards granted                           4 years      
Restricted stock unit award granted after one year                           1 year      
Award vesting on the first anniversary                           100.00%      
Maximum percent of shares allowed to purchase 10.00%                         10.00%      
Fair market value                           25,000      
Maximum number of shares allowed to purchase                           6,000      
Stock options granted                           213,000 151,000 145,000  
Weighted average grant date fair value                 $ 3.42 $ 4.09 $ 4.01 $ 3.66   $ 6.09 $ 6.85 $ 6.74  
Number of shares available for grant 14,213,000       6,414,000       6,414,000   8,205,000     14,213,000 6,414,000 8,205,000 9,851,000
Income tax (benefit) provision 13,096,000 [1],[2] 18,093,000 13,801,000 (8,015,000) (13,742,000) [3],[4] 14,384,000 40,605,000 [5] 7,680,000 [6]           36,975,000 48,927,000 (129,536,000)  
Advertising costs                           1,700,000 1,600,000 1,000,000  
Gains and losses on foreign exchange contracts                           6,900,000 4,500,000 900,000  
Exercise price                         $ 5.48        
Call option, shares                         34,700,000        
Warrant price 7.67                         7.67      
Foreign currency translation reclassification adjustment included in net income                               2,266,000  
Discrete Tax
                                 
Summary Of Significant Accounting Policies [Line Items]                                  
Income tax (benefit) provision       $ 6,700,000                          
Stock Options
                                 
Summary Of Significant Accounting Policies [Line Items]                                  
Percentage of common stock price                           100.00%      
Period of stock granted to employees and executive officers vest in equal installments                           4 years      
Employee Stock Purchase Plan
                                 
Summary Of Significant Accounting Policies [Line Items]                                  
Number of shares available for grant 6,400,000                         6,400,000      
[1] Interest expense and other includes a $34.2 million gain from the sale of an equity investment.
[2] In the fourth quarter ended December 31, 2013, pension and post retirement net actuarial gains increased gross profit and net income by $2.7 million and $9.1 million, respectively. See Note B: "Accounting Policies" for a discussion of our accounting policy.
[3] In the fourth quarter ended December 31, 2012, we corrected prior period income tax provision (benefit) errors that resulted in a $0.2 million income tax provision. These errors were not individually or in aggregate material to the fourth quarter of 2012 or any prior period.
[4] In the fourth quarter ended December 31, 2012, pension and postretirement actuarial losses decreased gross profit and net income by $8.1 million and $18.3 million, respectively. See Note B: "Accounting Policies" for a discussion of our accounting policy.
[5] Restructuring and other includes $0.3 million of severance charges related to headcount reductions of 10 people in Semiconductor Test and ($6.5) million fair value adjustment to decrease the LitePoint acquisition contingent consideration.
[6] Restructuring and other includes a ($1.8) million fair value adjustment to decrease the LitePoint acquisition contingent consideration.